The 2026 WHO dementia-prevention guideline recommends less PM2.5 — fine particulate matter — and less solid-fuel smoke for adults over 65 without dementia. The evidence supports a possible lower risk of cognitive decline or dementia, not assured prevention for any person.
The World Health Organization published the update on 15 July 2026 as the second edition after 2019, according to the guideline publication notice. It addresses adults living without dementia, including normal cognition and mild cognitive impairment. Both air-pollution actions are conditional and rest on very-low-certainty dementia-specific evidence, as summarized by Practical Risk Audit in its review of the WHO guideline.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Official resources:
- Read the official guidance from Who — Use this primary source to verify the official guidance.
- Read the official guidance from Who — Use this primary source to verify the official guidance.
Table of Contents
- Who this prevention advice covers
- What WHO advises for outdoor and indoor air
- What the PM2.5 studies show
- Steps that fit the evidence after 65
Who this prevention advice covers
The guideline speaks to adults without dementia. It includes people with normal thinking and people with mild cognitive impairment. Mild cognitive impairment means noticeable memory or thinking changes with largely independent daily life.
Adults over 65 without dementia fit this prevention group. The advice aims to lower future risk, not treat existing dementia. Caregivers can use it to support an older relative, not to replace medical care.
What WHO advises for outdoor and indoor air
WHO newly advises less exposure to ambient air pollution, especially PM2.5. The goal is possible lower risk or incidence of cognitive decline or dementia. GMJ News records this new recommendation in its account of the 2026 guideline. WHO also advises less household air pollution from solid-fuel cooking and heating.
The concern is smoke inside older households. Cleaner stoves, cleaner fuels, and better venting reduce that smoke. WHO frames both actions as conditional. Benefit is possible at population level, not promised for each person over 65. WHO news also places air pollution among 14 modifiable factors linked to up to 45% of dementia risk that could be prevented or delayed.
What the PM2.5 studies show
Alzheimer Europe summarizes a Lancet Planetary Health review of 32 long-term studies in over 24 million adults. It reports higher dementia diagnosis with higher PM2.5, pooled hazard ratio 1.08 per 5 µg/m³ increase, in its summary of the meta-analysis. The link supports but does not prove causation.
EMJ Reviews notes very high variation between studies, I² at 95%. The studies were observational, with different exposure measures. Residual confounding can still shape results for adults over 65.
Steps that fit the evidence after 65
The World Health Organization gives a clear outdoor benchmark in the WHO air-quality spotlight. Keep annual mean PM2.5 at or below 5 µg/m³. Keep 24-hour mean at or below 15 µg/m³.
Use the benchmark to guide daily choices. Older adults can favor ventilation, clean fuels, and lower-traffic routes. If your home uses wood, coal, or crop waste for cooking, seek stove venting and fuel advice from a health or energy program. Bring heart, lung, and hearing concerns to the same visit, since dementia prevention works across risks.
- Ventilate cooking and heating areas and move away from solid fuels where you can.
- Walk or exercise away from heavy traffic when air looks or smells smoky.
- Check local air-quality reports before long outdoor time.
You Might Also Like
- Cross-Cultural Dementia Risk Programs After LatAm-FINGERS 2026: What the Evidence Supports and Does Not Promise for Adults Over 65
- Injection Training for the 2026 At-Home Leqembi Regimen: Benefits, Limits, and Evidence Gaps for People With Mild Cognitive Impairment
- At-Home Leqembi vs IV Infusions After the 2026 FDA Decision: Benefits, Limits, and Evidence Gaps for People With Mild Cognitive Impairment
